Nyquil D

Quick links to important sections

Nyquil D

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nyquil D

What is Nyquil D? (Product Overview)

Property Description
Active Ingredient Acetaminophen, Dextromethorphan, Doxylamine, Pseudoephedrine
Form Oral liquid solution, Caplet
Pharmacological Class Upper Respiratory Combination
Common Use Symptomatic relief of cold/flu discomforts
Origin Synthetic chemical compounds

What Type of Preparation is Nyquil D?

Nyquil D is a fixed-dose combination medication classified as a multi-symptom cold relief preparation, designed for the comprehensive symptomatic relief of upper respiratory tract symptoms. This preparation is composed entirely of four distinct synthetic chemical compounds and is typically administered via the oral route. It falls within the broad Pharmacological class of combination agents that address multiple symptoms simultaneously. This combination of ingredients is clinically recognized for treating symptoms associated with upper respiratory infections and allergic rhinitis.

What are the Active Ingredients in Nyquil D?

The composition of Nyquil D is defined by its four functional active ingredients. Acetaminophen functions as an analgesic and antipyretic (fever-reducing) agent, while Dextromethorphan is included for its function as a cough suppressant (antitussive). The third ingredient, Doxylamine, acts as a sedating antihistamine, and the final component, Pseudoephedrine, is classified as a sympathomimetic amine that operates as a potent nasal decongestant. The combination of these specific agents—particularly the inclusion of Pseudoephedrine alongside the sedating H1 antagonist Doxylamine—provides a differentiating feature, positioning the preparation for comprehensive relief when congestion is severe.

What is the General Purpose of Nyquil D?

The general purpose of this specific formulation is to mitigate the temporary distress caused by the common cold and flu, facilitating patient comfort and rest. By combining agents for pain and fever relief with compounds to suppress cough and relieve nasal congestion, the preparation is intended to provide a functional solution to the primary sources of cold and flu distress. The presence of Doxylamine, a compound known to promote drowsiness, specifically aligns this preparation for use when comprehensive relief and the promotion of sleep are desired, such as when nasal congestion and cough are interrupting the user's rest.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. DailyMed Label for Vicks NyQuil-D Cold and Sinus

What side effects are possible with Nyquil D?

Possible Side Effects and Safety Information

The safety profile of this preparation is defined by the officially documented effects of its four active ingredients: Acetaminophen, Dextromethorphan, Doxylamine, and Pseudoephedrine. Adverse reactions are classified based on the frequency of their occurrence in regulatory documentation, often grouped by the physiological system affected.

Documented Adverse Reactions

Reactions classified as Common frequently involve the Central Nervous System and Gastrointestinal System. The Doxylamine component contributes to commonly reported effects such as drowsiness and sedation. Other frequently documented reactions include dizziness, headache, nausea, and dry mouth.

Less frequent, or Uncommon to Rare, adverse reactions include insomnia and nervousness (related to the Pseudoephedrine component), as well as potential for hypertension and tachycardia.

Serious Adverse Reactions and Safety Constraints

The most critical safety characteristic defined in regulatory labeling involves the risk of Acute Liver Failure tied to the Acetaminophen component, a serious adverse reaction associated with exceeding the maximum recommended daily amount. Rare but serious reactions, such as Severe Cutaneous Adverse Reactions (SCARs) and severe allergic responses, are also documented.

Safety constraints mandate that the preparation should not be used in individuals with severe hepatic disease due to the Acetaminophen content, or those with severe uncontrolled hypertension or coronary artery disease due to the Pseudoephedrine component. Older adults may be more susceptible to effects such as sedation and urinary retention.

Overdose and Emergency Response

Overdose and When to Seek Help

Immediate medical attention is critically required for all suspected overdoses involving this multi-ingredient product, even if the individual has no noticeable symptoms. Overdose information is primarily governed by the toxicity profile of the active components: Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, and Phenylephrine HCl.

Documented Manifestations and Serious Risks

Component Documented Manifestations (Early) Serious Outcomes (Life-Threatening)
Acetaminophen Nausea, vomiting, loss of appetite, sweating, stomach/abdominal pain. Severe liver damage or fatal liver disease.
Dextromethorphan Agitation, confusion, unsteadiness, fast heartbeat. Respiratory depression, coma, seizures.
Combined Sympathomimetics/Antihistamines Flushing, hallucinations, high blood pressure. Severe cardiovascular events.

Required Emergency Actions

The most important regulatory instruction is to contact a Poison Control Center or seek emergency medical help right away following any suspected overdose. This action is critical because liver damage from the Acetaminophen component may progress silently for hours before symptoms appear. Overdose management in a medical setting often involves monitoring vital signs, administering activated charcoal, and in severe cases, providing breathing support or specific antidotes for the toxic components. Risk is heightened when more than the maximum daily dose is taken, or when the medicine is combined with other acetaminophen-containing products or alcohol.

Therapeutic Uses of Nyquil D

What Nyquil D Treats: Main Uses and Benefits

This combination product is generally used in situations involving certain distressing symptoms associated with the common cold and flu. It is applied in clinical settings that involve acute or unstable symptom patterns, addressing manifestations that commonly cluster during periods of illness.


This therapeutic domain is relevant in contexts involving heightened systemic burden, with the medication used in situations involving certain distressing symptoms such as fever, headache, body aches, nasal congestion, and cough. The preparation helps address symptom clusters related to systemic imbalance and inflammatory states.

“The combination supports the patient during difficult episodes by easing distress and supports functional stability when symptoms interfere with routine activities.”

Quick Fact: Relief for Congestion and Interrupting Symptoms

Nyquil D is commonly used when symptoms intensify and supportive relief is needed, particularly addressing symptoms that become more disruptive during flare-ups, such as congestion contributing to noticeable physiological strain. This support may assist with maintaining a sense of stability when symptoms interfere with daily comfort or sleep.

Regulatory References

  1. NIH DailyMed listing for Nyquil-D Cold and Sinus

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Nyquil D

The official eligibility for Nyquil D is strictly defined by regulatory guidelines. The medicine is approved for use by adults and adolescents aged 12 years and older.

Absolute Prohibitions (Contraindications): Nyquil D must not be used by certain high-risk populations, as explicitly stated in the regulatory labeling:

  • Children under 12 years of age.
  • Patients currently taking or who have taken a Monoamine Oxidase Inhibitor (MAOI) within the past two weeks.
  • Individuals taking any other medicine containing acetaminophen to mitigate the risk of severe liver damage.
  • Patients with a known allergy to any component of the product.

Conditional Use (Consultation Required): Use is restricted and requires consultation with a health professional for individuals with specific health conditions, including:

  • Liver disease, Heart disease, or High Blood Pressure.
  • Thyroid disease or Diabetes.
  • Glaucoma or difficulty with urination due to an enlarged prostate gland.
  • Cough that is chronic or produces excessive phlegm.
  • Individuals who are pregnant or breast-feeding.

These limitations are based on the product’s multi-ingredient composition and the need to ensure population safety under labeled conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This product contains multiple active ingredients, including acetaminophen and a cough suppressant, which carry documented risks for severe interactions with certain medicines and substances. Adherence to label warnings is essential to avoid potentially dangerous combinations.


Product or Substance Category Official Interaction Constraint
Monoamine Oxidase Inhibitors (MAOIs) DO NOT USE. Taking this medicine with a prescription MAOI, or for two weeks after stopping an MAOI, is strictly contraindicated. This is a major interaction risk.
Other Acetaminophen-containing Drugs DO NOT USE. Do not combine with any other medicine containing acetaminophen (either prescription or nonprescription) to prevent the risk of severe liver damage.
Alcoholic Beverages AVOID. The use of this medicine with alcoholic drinks is prohibited, as consuming three or more drinks per day while using it can significantly increase the risk of severe liver damage. Alcohol may also increase drowsiness.
Sedatives or Tranquilizers Consult a Doctor/Pharmacist. These agents may increase the marked drowsiness caused by this medicine. Professional advice is required before concurrent use.
Warfarin (Blood-thinning drug) Consult a Doctor/Pharmacist. Professional consultation is necessary before use, as the acetaminophen component may interact with warfarin and affect the blood-thinning effect.

Official regulatory labeling for this combination product defines the core interaction profile through absolute contraindications with MAOIs and any other source of acetaminophen, emphasizing the high risk of liver toxicity and hypertensive crisis. The profile further mandates professional consultation before concurrent use with central nervous system depressants or the anticoagulant warfarin, highlighting the potential for augmented sedation and altered bleeding risk.

Mechanism of Action

Nyquil D’s pharmacodynamics are governed by four distinct molecular entities: acetaminophen, dextromethorphan, doxylamine, and pseudoephedrine.

Acetaminophen modulates cellular processes primarily within the central nervous system. It functions by inhibiting cyclooxygenase enzymes, predominantly COX-2, decreasing the synthesis of prostaglandins (PGE2). This reduction in prostaglandin concentration within the hypothalamus diminishes the activity of the thermoregulatory center, modulating systemic temperature. Its analgesic action involves multiple central pathways, potentially including the serotonergic descending inhibitory pathway.

Dextromethorphan acts as a non-competitive antagonist at the N-methyl-D-aspartate (NMDA) receptor in the central nervous system, particularly in the brainstem's cough center (nucleus tractus solitarius). This interaction reduces the transmission of afferent cough stimuli, thereby elevating the central threshold for the cough reflex. Dextromethorphan also acts as a Sigma-1 receptor agonist.

Doxylamine is an inverse agonist that selectively targets the Histamine H1 receptor in both peripheral tissues and the central nervous system. Its binding to H1 receptors blocks the action of histamine, thereby modulating cellular cascades regulated by this receptor. Its central activity is responsible for systemic sedative effects.

Pseudoephedrine is a sympathomimetic agent functioning as a direct agonist at alpha1-adrenergic receptors on vascular smooth muscle, especially in the microvasculature of the nasal mucosa. Receptor binding triggers intracellular signaling, leading to vasoconstriction. This systemic vascular modulation diminishes local blood flow and reduces capillary filtration pressure in the targeted tissue.

Dosage and Administration Information

How to Use Nyquil D: Administration Guidelines

This section details the instructions for administering Nyquil D (Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Pseudoephedrine HCl).

Route and Dosage Form

The approved route of administration is oral. The medication is available in the form of a Liquid-filled Capsule (LiquiCap). Each LiquiCap contains a fixed combination of active ingredients, including acetaminophen 500 mg and pseudoephedrine HCl 30 mg.

Standard Dosing and Frequency

Standard parameters define the amounts and timing for use:

Usage Parameter Instruction (Adults 12 years and older)
Single Dose 2 LiquiCaps, taken with water
Frequency Every 6 hours as needed for acute symptoms
Maximum Dose Do not exceed 6 LiquiCaps per 24 hours

Administration Conditions and Duration

The usage protocol establishes clear limits on the application and duration of use:

  • Age Restriction: Nyquil D is not intended for use in children under 12 years of age.
  • Duration of Use: The product is intended for short-term, acute relief. Instructions advise discontinuing use if pain, nasal congestion, or cough lasts more than 7 days, or if fever persists for more than 3 days.
  • Procedural Steps: The LiquiCaps should be taken only as directed and swallowed with water. No special preparation, such as dilution or mixing, is required.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Nyquil D

Evidence for Relief of Pain and Fever (Acetaminophen)

Research has explored how the acetaminophen component of this medication was studied for temporary symptom changes, specifically outcomes related to temporary pain (e.g., headache, minor aches) and the temporary lowering of fever. Studies mainly involved short-term randomized controlled trials applied in research contexts involving fluctuating or unstable symptoms. Findings describe patterns observed in the studies where measurements of pain intensity or fever were reported over the course of the study period. However, results apply only to the populations studied, and comparative evidence is lacking for certain cold and flu combinations against other pain and fever relievers.

Evidence for Temporary Cough Suppression (Dextromethorphan)

The dextromethorphan component was evaluated in studies examining how the drug was studied for temporary cough suppression related to throat and bronchial irritation. Research primarily consisted of short-term randomized trials that explored changes measured in the frequency or intensity of coughing. Research so far studies monitor that findings describe patterns observed in the studies related to inflammatory or irritative states. Data for certain groups remain insufficient, particularly children under the age of four, and follow-up durations were limited.

Evidence for Temporary Nasal and Sinus Congestion Relief (Pseudoephedrine)

Studies exploring the pseudoephedrine component was studied for temporary relief of nasal and sinus congestion. The research examined changes in outcomes reflecting daily functioning affected by blocked nasal passages. Findings research describes patterns where participants reported changes measured in their nasal airflow or the sensation of fullness. Subgroup findings are uncertain, as the evidence quality varies across studies.

What is Still Uncertain About Nyquil D

Research exploring long-term effects are not fully established for the components of this cold medication, as it is designed for short-term, temporary symptom relief. The majority of clinical evidence consists of trials with defined follow-up durations that covered the acute symptom period. Evidence is limited regarding the comprehensive effects of all four active ingredients working together across various subgroups. Data for certain groups remain insufficient, and certainty remains low regarding the chronic use of this medication.

Key Studies & References

  1. Acetaminophen for the common cold (Cochrane Review)
  2. Dextromethorphan for cough (Cochrane Review)

Frequently Asked Questions (FAQ)

Common questions about Nyquil D (FAQ)


Q: Is Nyquil D a cold medicine or a flu medicine?

Regulatory product labeling states that the drug is intended for the temporary relief of symptoms associated with both the common cold and the flu.

It is classified as a multi-symptom relief preparation designed to address distress caused by symptoms common to both conditions.


Q: Can Nyquil D be taken during the day?

Official warnings explicitly state that marked drowsiness may occur when using this product due to the antihistamine component.

Because of this, the label advises caution and avoiding activities like operating a motor vehicle or heavy machinery while taking it.


Q: Is it common to feel jittery or restless after taking Nyquil D?

Product warnings instruct users to discontinue use and consult a professional if they experience feelings of nervousness or sleeplessness.

These side effects are documented and are linked to the pseudoephedrine component.


Q: Are there any common over-the-counter medicines that should not be taken with Nyquil D?

The most critical warning strictly prohibits use with any other medicine containing acetaminophen, whether prescription or nonprescription.

This is a safety constraint mandated to prevent the risk of exceeding the safe daily limit of acetaminophen, which can cause severe liver damage.


Q: Why is Nyquil D often described as a 'multi-symptom' product?

It is classified as 'multi-symptom' because its formula contains four different active ingredients, with each ingredient targeting a separate symptom.

These ingredients provide relief for pain/fever, cough, sneezing, and nasal congestion simultaneously.


Q: Do any regulatory documents discuss the possibility of misuse with Nyquil D?

Official labeling includes warnings regarding the serious risks of overdosage, which can lead to severe liver damage from the acetaminophen component.

It strictly mandates that users do not exceed the maximum daily dose.


Q: How long does the drowsy feeling from Nyquil D typically last?

The doxylamine succinate ingredient, which contributes to the drowsy feeling, is described in general drug information as having a duration of action of approximately six to eight hours.

The established dosing frequency is every six hours.


Q: Why does Nyquil D sometimes cause difficulty falling asleep for some people?

Official product warnings note that the medicine may cause effects like sleeplessness (insomnia) or nervousness.

These side effects are documented and primarily linked to the pseudoephedrine component, which is included to relieve congestion.


Q: Can Nyquil D be taken by someone who has diabetes?

According to the official regulatory information, diabetes is listed as a pre-existing condition.

Individuals with this condition are included in the guidance that requires consultation with a health professional before using the product.


Q: Can Nyquil D be used while taking a common antidepressant?

The warnings strictly prohibit use with prescription Monoamine Oxidase Inhibitors (MAOIs).

Consultation with a health professional is also advised before use with other types of sedatives or tranquilizers to avoid potentially increasing drowsiness.


Q: How does Nyquil D compare to DayQuil D in terms of ingredients?

Nyquil D is differentiated by its inclusion of the sedating antihistamine, doxylamine succinate, which is intended to promote rest.

The daytime formula (DayQuil D) typically substitutes or removes this sedating ingredient to achieve non-drowsy relief while still containing the decongestant component.


Q: What is the significance of the 'D' in Nyquil D?

The 'D' in the product name typically denotes the presence of a decongestant component in the formula.

In Nyquil D, this ingredient is Pseudoephedrine HCl, which is included for the temporary relief of nasal congestion.


Q: Are there different versions of Nyquil D for children and adults?

Official regulatory labeling for this product restricts its use based on age.

It is explicitly stated as not intended for use in children under 12 years of age, and regulatory documentation does not describe a separate NyQuil D formulation for children.


Q: Is Nyquil D considered a controlled substance in any region?

The decongestant component, pseudoephedrine, is subject to specific federal and state sales restrictions and monitoring in the United States.

This regulation reflects the ingredient’s potential for use in the illicit manufacture of other substances.


Q: Can taking Nyquil D affect the results of any common medical tests?

Drug information summaries for the components note that certain ingredients, such as the pain reliever acetaminophen, may potentially interfere with the results of specific laboratory tests.

This is sometimes seen with certain urine drug screening tests.


Q: Can Nyquil D be used by people with asthma?

According to official regulatory warnings, asthma is listed as a pre-existing breathing problem.

Individuals with this condition are included in the regulatory guidance that requires consultation with a health professional before use.


Q: Is the pain reliever in Nyquil D an NSAID?

The pain reliever in this product is Acetaminophen.

Regulatory documents classify acetaminophen as separate from the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) class, which includes medicines like ibuprofen or naproxen.


Q: What are the most common side effects mentioned in product information for Nyquil D?

Regulatory documents list common effects, which frequently involve the central nervous and gastrointestinal systems.

These commonly reported effects include drowsiness, dizziness, headache, nausea, and dry mouth.


Q: Why do official sources state that Nyquil D should not be used for more than a few days?

The preparation is intended for short-term, temporary relief of acute cold and flu symptoms.

Warnings advise users to discontinue use if symptoms such as pain or cough persist for more than seven days, or if fever lasts longer than three days.


Q: Do any official documents describe Nyquil D causing stomach upset?

Official side effect information, which is derived from regulatory reporting, lists nausea and vomiting among the commonly reported effects associated with the product.

While not explicitly labeled 'stomach upset,' these are related gastrointestinal reactions.


Q: Is Nyquil D typically associated with dry mouth or nose?

Official side effect information lists dry mouth as a commonly reported effect due to the action of the antihistamine component.

Dry nose is not explicitly listed among the common adverse reactions.


Q: Do regulatory agencies list any rare but serious side effects for Nyquil D?

Yes, official safety warnings emphasize the risk of Severe Liver Damage linked to the acetaminophen ingredient if the maximum dose is exceeded.

They also list potential for rare, serious reactions like severe allergic responses or severe cutaneous reactions (SCARs).


Q: Is there any information on Nyquil D use in the elderly population?

Official safety constraints note that older adults may be more susceptible to certain effects of the active ingredients.

These documented effects include potential for increased sedation or difficulty with urination.


Q: What is the duration of action for the decongestant ingredient in Nyquil D?

The established dosing schedule for the product is every 6 hours.

This interval is established to maintain concentrations of the active ingredients throughout the dosing period.


Q: Why are official product documents very specific about taking no other cold medicines with Nyquil D?

The primary reason for this instruction is the risk of severe liver damage.

Official warnings state that combining this product with any other medicine containing acetaminophen can lead to a toxic overdose.

How should Nyquil D be stored and disposed of?

Storage & Disposal Scope

Labeled Storage Temperature Requirements Store at controlled room temperature, specifically between 20 C and 25 C (68 F to 77 F). Protect from excessive heat.
Light/Moisture Protection Requirements Protect from light and moisture. Do not store in the bathroom.
Stability after Opening/Reconstitution Use the product only before the expiration date printed on the package.
Handling Requirements The liquid formulation is directed not to be refrigerated and not to be frozen.
Packaging-related Storage Rules Keep the medicine in the original container and ensure it is tightly closed.
Disposal Instructions Preferred method is a drug take-back program. If unavailable, dispose of in household trash after mixing the medicine with an undesirable substance (like cat litter) and sealing it.
Environmental or Controlled-Waste Disposal Requirements Do not flush medications down the toilet or pour them into a drain unless specific labeling instructs you to do so.
Child-Protection Storage Requirements Keep all medications out of the sight and reach of children and pets.

Storage/Disposal Classifications (High-Level)

Storage Condition Type Room temperature, protect from light, protect from moisture.
In-use Stability Classification Use before the labeled expiration date; subject to loss of potency under excessive heat.
Regulatory Basis FDA / DailyMed, NIH / MedlinePlus.
Storage-Context Constraints Do not refrigerate; do not freeze; keep tightly closed; store away from children.

Resulting Storage & Disposal Structure

Official regulatory documents define how NyQuil D must be stored by setting explicit temperature limits and environmental protection rules (against light/moisture) to maintain product stability and potency. Handling requirements include the explicit prohibition of cold environments and mandatory child-safety storage. Disposal instructions are dictated by government guidelines that favor take-back systems or a specific, mandatory household trash procedure to prevent environmental contamination and accidental ingestion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Nyquil D found in:

A-Z Index: